Literature DB >> 14716122

Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.

S Ghosh1, S C Shinde, G S Kumaran, R S Sapre, S R Dhond, Y Badrinath, R Ansari, A Kumar, S Mahadik, A B Chougule, C N Nair.   

Abstract

OBJECTIVES: To study the hematologic and immunophenotypic profile of 260 cases of acute myeloid leukemia at diagnosis.
MATERIAL AND METHODS: This is a retrospective analysis of 260 cases of AML diagnosed at our institution between 1998 and 2000. Diagnosis was based on peripheral blood and bone marrow examination for morphology cytochemistry and immunophenotypic studies. SPSS software package, version 10, was used for statistical analysis.
RESULTS: Seventy-six percent of our cases were adults. The age of the patients ranged from one year to 78 years with a median age of 27.2 years. There were 187 males and 73 females. The commonest FAB subtype, in both children and adults, was AML-M2. The highest WBC counts were seen in AML-M1 and the lowest in AML-M3 (10-97 x 10(9)/L, mean 53.8 x 10(9)/L). The mean values and range for hemoglobin was 6.8 gm/l (1.8 gm/l to 9.2 gm/l), platelet count 63.3 x 10(9)/L (32-83 x 10(9)/L), peripheral blood blasts 41.4% (5 to 77%) and bone marrow blasts 57.6% (34-96%). Myeloperoxidase positivity was highest in the M1, M2 and M3 subtypes. CD13 and CD33 were the most useful markers in the diagnosis of AML. CD14 and CD36 were most often seen in monocytic (38%) and myelomonocytic (44%) leukemias. Lymphoid antigen expression was seen in 15% of cases. CD7 expression was the commonest (11%).
CONCLUSION: AML accounted for 39.8% of all acute leukemias at this institution. The most common subtype was AML-M2. Myeloperoxidase stain was a useful tool in the diagnosis of myeloid leukemias. CD13 and CD33 were the most diagnostic myeloid markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14716122

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

1.  Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience.

Authors:  Dalia A Salem; Sherin M Abd El-Aziz
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-21       Impact factor: 0.900

2.  Clinical Profile and Short Term Outcome of Adult Patients with Acute Myeloid Leukemia.

Authors:  Sherin Jacob; Sajini Elizabeth Jacob; Bettadpura Shamanna Suryanarayana; Tarun Kumar Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-26       Impact factor: 0.900

3.  Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study.

Authors:  Akhil Kapoor; Surender Kumar Beniwal; Ashok Kalwar; Mukesh Kumar Singhal; Raj Kumar Nirban; Harvindra Singh Kumar
Journal:  South Asian J Cancer       Date:  2016 Apr-Jun

4.  Characteristics of De Novo Acute Myeloid Leukemia Patients in Palestine: Experience of An-Najah National University Hospital

Authors:  Ziad Abuhelwa; Qasem Al Shaer; Sari Taha; Khubaib Ayoub; Riad Amer
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

5.  Leukemic gingival enlargement: A case report and review of literature.

Authors:  Kanika Chowdhri; Shruti Tandon; Arundeep Kaur Lamba; Farrukh Faraz
Journal:  J Oral Maxillofac Pathol       Date:  2018-01

6.  Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML).

Authors:  Maria Basharat; Saleem Ahmed Khan; Nasir Ud Din; Dawood Ahmed
Journal:  Pak J Med Sci       Date:  2019 Mar-Apr       Impact factor: 1.088

7.  Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience.

Authors:  Nishit Gupta; Ravikiran Pawar; Sambhunath Banerjee; Subhajit Brahma; Asish Rath; Sundar Shewale; Mayur Parihar; Manish Singh; S R Arun; Shekhar Krishnan; Arpita Bhatacharyya; Anirban Das; Jeevan Kumar; Saurabh Bhave; Vivek Radhakrishnan; Reena Nair; Mammen Chandy; Neeraj Arora; Deepak Mishra
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576

8.  Interleukin-10 (1082G/A) Polymorphism is Associated with Susceptibility of Acute Myeloid Leukemia Patients in Sudanese Population.

Authors:  Omnia Mohamed Sharif; Rosline Hassan; Ameen Abdulaziz Mohammed Basbaeen; Ayman Hussien Mohmed; Ibrahim Khider Ibrahim
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.